Skip to content

Clinical trials

Phase 3 Hematologic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 3 Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20072
20083
20092
20101
20111
20121
20132
20141
20151
20161
20172
20181
20191
20205
20211
20222
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting8
Terminated5
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
M.D. Anderson Cancer Center4
Novartis Pharmaceuticals4
Children's Oncology Group3
Alliance for Clinical Trials in Oncology2
Gamida Cell ltd2
Academic and Community Cancer Research United1
Amgen1
Augusta University1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms38
Leukemia5
Multiple Myeloma5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Leukemia, Myeloid, Acute4
Myelodysplastic Syndromes4
Bone Marrow Diseases3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Neoplasms3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.